IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Clinical trial NCT05365659 · RECRUITING

Trial details

NCT number: NCT05365659
Sponsor: Iksuda Therapeutics Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma B-cell Lymphoma

Start date: 2023-09-05
Primary completion: 2027-09-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.